FMR CORP 13D/13G Filings for Kinnate Biopharma Inc. (KNTE)

FMR CORP 13D and 13G filings for Kinnate Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-09
09:22 am
Sale		 2022-02-08 13G Kinnate Biopharma Inc.
KNTE		 FMR CORP 2,092,523
4.788%		 -357,612decrease
(-14.60%)		 Filing
2021-02-08
10:25 am
Purchase		 2021-02-05 13G Kinnate Biopharma Inc.
KNTE		 FMR CORP 2,450,135
5.654%		 2,450,135increase
(New Position)		 Filing